Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,200
Closed -$72K – 5349
2021
Q3
$72K Sell
1,200
-3,086
-72% -$181K ﹤0.01% 2189
2021
Q2
$257K Buy
4,286
+1,238
+41% +$62K 0.01% 1161
2021
Q1
$143K Sell
3,048
-2,700
-47% -$111K 0.01% 1498
2020
Q4
$216K Sell
5,748
-8,638
-60% -$285K 0.01% 1042
2020
Q3
$470K Buy
+14,386
New +$609K 0.03% 554
2020
Q2
– Sell
-500
Closed -$25.5K – 4350
2020
Q1
$22K Sell
500
-200
-29% -$9.05K ﹤0.01% 2231
2019
Q4
$30K Buy
+700
New +$28.5K ﹤0.01% 1959

Other funds holding ATEX

Cutler Group's ATEX Position: Q4 2021 in Review

Cutler Group sold out of Anterix (ATEX) in Q4 2021, closing a stake of 1,200 shares — an estimated $72K sold.

Cutler Group first reported a position in ATEX in Q4 2019 and held it in 7 quarters. The position peaked at $470K in Q3 2020. 108 funds tracked by Wall St. Rank hold ATEX as of Q4 2021.

  • Cutler Group reported no remaining Anterix position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 1,200 Anterix shares in Q4 2021, an estimated $72K.
  • Cutler Group first reported a position in Anterix in Q4 2019 and held it in 7 quarters.
  • Cutler Group's Anterix position peaked at $470K in Q3 2020.
  • 108 funds tracked by Wall St. Rank held Anterix as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.